Real-world adherence to and persistence with emicizumab in people with hemophilia A using a national claims database
In the first year following emicizumab initiation, high adherence and low discontinuation rates were observed among PwHA in a real-world setting.
Authors
- Zhiyu Xia
- Janet S. Lee
- Juliana M. L. Biondo
- Robert Schuldt
- Amy D. Shapiro
- Lucy Lee
Institutions
- Indiana Hemophilia and Thrombosis Center (US)
Publication Details
- Journal
- Journal of Managed Care & Specialty Pharmacy
- Published
- 2026-02-01
- DOI
- https://doi.org/10.18553/jmcp.2026.32.2.135
- Primary Topic
- Hemophilia Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00